AliveDx
At AliveDx, our mission is to empower diagnostic insights, transform patient care, and innovate for life. With over 30 years in in-vitro diagnostics, we are dedicated to shaping the future of global diagnostics in autoimmune, allergy, and beyond. Our groundbreaking solutions empower laboratories and clinicians to accelerate diagnosis, improving patients' lives while fostering a positive and sustainable work environment for healthcare providers. Our portfolio includes the Alba, MosaiQ and LumiQ brands. These solutions aim to generate both economic and clinical value by simplifying laboratory workflows and providing fast, accurate results that enhance clinical decision-making. At AliveDx, we innovate for life.
Content by AliveDx
Updated |2 min read
AliveDx's MosaiQ® Platform Registered with FDA as Class II 510(k) Exempt, Enabling US Labs to Adopt High-Throughput Automated Immunoassay Testing
MosaiQ is a next-gen immunoassay platform delivering automated, multiplexed testing and actionable insights for complex conditions
|2 min read
New Multiplex Assay Aims to Accelerate Diagnosis of Autoimmune Vasculitis
A new CE-marked test for MPO, PR3, and anti-GBM autoantibodies offers faster, simplified serological evaluation and may help labs streamline workflows in vasculitis testingPage 1 of 1
